28 Grants (Page 1 of 2)
2024
The mitochondrial genome in lung disease: a signaling hub linking the persistence and severity of inflammation to recovery
Audia, Jonathon P⋅Gillespie, Mark N and GILLESPIE, MARK N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL169587-01A1), $652,078USD, 2024-03-15 -- 2028-02-29
2016
MtDNA repair: An isolated pharmacologic target in acute lung injury
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 4R01HL113614-05), $371,250USD, 04/16/2012 -- 02/28/2017
2015
MtDNA repair: An isolated pharmacologic target in acute lung injury
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL113614-04), $365,681USD, 04/16/2012 -- 02/29/2016
2014
MtDNA repair: An isolated pharmacologic target in acute lung injury
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL113614-03), $363,825USD, 04/16/2012 -- 02/28/2017
2013
MtDNA repair: An isolated pharmacologic target in acute lung injury
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL113614-02), $353,430USD, 04/16/2012 -- 02/28/2017
2012
MtDNA repair: An isolated pharmacologic target in acute lung injury
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL113614-01), $371,250USD, 04/16/2012 -- 02/28/2017
2009
Lung Cell Genomic Threats from Physiological Signals
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL073244-05), $346,086USD, 04/01/2005 -- 03/31/2011
2008
Lung Cell Genomic Threats from Physiological Signals
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL073244-04), $346,086USD, 04/01/2005 -- 03/31/2010
2007
Lung Cell Genomic Threats from Physiological Signals
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL073244-03), $346,086USD, 04/01/2005 -- 03/31/2010
2006
Lung Cell Genomic Threats from Physiological Signals
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL073244-02), $356,423USD, 04/01/2005 -- 03/31/2010
2005
Lung Cell Genomic Threats from Physiological Signals
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL073244-01A2), $365,000USD, 04/01/2005 -- 03/31/2010
1999
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL038495-12), 12/20/1990 -- 06/30/2001
1998
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL038495-11), 12/20/1990 -- 06/30/2000
1997
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL038495-10), 12/20/1990 -- 06/30/2000
1996
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R01HL038495-09), 12/20/1990 -- 06/30/2000
1995
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 7R01HL038495-08), 12/20/1990 -- 06/30/1996
1994
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL038495-07), 12/20/1990 -- 11/30/1994
1993
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL038495-06), 12/20/1990 -- 11/30/1995
1992
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL038495-05), 12/20/1990 -- 11/30/1995
 
POLYAMINES IN HYPOXIC PULMONARY HYPERTENSION
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K04HL002174-05), 08/01/1988 -- 07/31/1993
1991
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R01HL038495-04A1), 12/20/1990 -- 11/30/1995
 
POLYAMINES IN HYPOXIC PULMONARY HYPERTENSION
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K04HL002174-04), 08/01/1988 -- 07/31/1993
1990
POLYAMINES IN HYPOXIC PULMONARY HYPERTENSION
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K04HL002174-03), 08/01/1988 -- 07/31/1993
1989
HYPOXIC PULMONARY HYPERTENSION AND POLYAMINES
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R29HL038495-03), 04/01/1987 -- 03/31/1991
 
POLYAMINES IN HYPOXIC PULMONARY HYPERTENSION
Gillespie, Mark N
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K04HL002174-02), 08/01/1988 -- 07/31/1993